These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 17008014)

  • 1. Targeted therapies in melanoma.
    Queirolo P; Acquati M
    Cancer Treat Rev; 2006 Nov; 32(7):524-31. PubMed ID: 17008014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emerging therapies for melanoma.
    Katipamula R; Markovic SN
    Expert Rev Anticancer Ther; 2008 Apr; 8(4):553-60. PubMed ID: 18402522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiogenesis in cutaneous malignant melanoma and potential therapeutic strategies.
    Basu B; Biswas S; Wrigley J; Sirohi B; Corrie P
    Expert Rev Anticancer Ther; 2009 Nov; 9(11):1583-98. PubMed ID: 19895243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospects for non-immunological molecular therapeutics in melanoma.
    Eustace AJ; Mahgoub T; Tryfonopoulos D; O'Donovan N; Crown J
    J BUON; 2010; 15(1):9-18. PubMed ID: 20414921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel treatment strategies for malignant melanoma: a new beginning?
    Kasper B; D'Hondt V; Vereecken P; Awada A
    Crit Rev Oncol Hematol; 2007 Apr; 62(1):16-22. PubMed ID: 17208006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemotherapy and targeted therapy combinations in advanced melanoma.
    Flaherty KT
    Clin Cancer Res; 2006 Apr; 12(7 Pt 2):2366s-2370s. PubMed ID: 16609060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metastatic melanoma: scientific rationale for sorafenib treatment and clinical results.
    Egberts F; Kahler KC; Livingstone E; Hauschild A
    Onkologie; 2008 Jul; 31(7):398-403. PubMed ID: 18596389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advances in targeted therapy for unresectable melanoma: new drugs and combinations.
    Hao M; Song F; Du X; Wang G; Yang Y; Chen K; Yang J
    Cancer Lett; 2015 Apr; 359(1):1-8. PubMed ID: 25578781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of metastatic melanoma 2005.
    O'Day S; Boasberg P
    Surg Oncol Clin N Am; 2006 Apr; 15(2):419-37. PubMed ID: 16632224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overcoming apoptosis deficiency of melanoma-hope for new therapeutic approaches.
    Eberle J; Kurbanov BM; Hossini AM; Trefzer U; Fecker LF
    Drug Resist Updat; 2007 Dec; 10(6):218-34. PubMed ID: 18054518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemic therapy for metastatic malignant melanoma--from deeply disappointing to bright future?
    Lorigan P; Eisen T; Hauschild A
    Exp Dermatol; 2008 May; 17(5):383-94. PubMed ID: 18312390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecularly targeted therapy for melanoma: current reality and future options.
    Becker JC; Kirkwood JM; Agarwala SS; Dummer R; Schrama D; Hauschild A
    Cancer; 2006 Nov; 107(10):2317-27. PubMed ID: 17039502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experimental therapy of malignant mesothelioma: new perspectives from anti-angiogenic treatments.
    Catalano A; Gianni W; Procopio A
    Crit Rev Oncol Hematol; 2004 May; 50(2):101-9. PubMed ID: 15157659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The promise of molecular targeted therapies: protein kinase inhibitors in the treatment of cutaneous malignancies.
    Kondapalli L; Soltani K; Lacouture ME
    J Am Acad Dermatol; 2005 Aug; 53(2):291-302. PubMed ID: 16021125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New therapeutic targets in melanoma.
    Martí RM; Sorolla A; Yeramian A
    Actas Dermosifiliogr; 2012 Sep; 103(7):579-90. PubMed ID: 22261672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatments for metastatic melanoma: synthesis of evidence from randomized trials.
    Lui P; Cashin R; Machado M; Hemels M; Corey-Lisle PK; Einarson TR
    Cancer Treat Rev; 2007 Dec; 33(8):665-80. PubMed ID: 17919823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A phase II study of thalidomide in patients with brain metastases from malignant melanoma.
    Vestermark LW; Larsen S; Lindeløv B; Bastholt L
    Acta Oncol; 2008; 47(8):1526-30. PubMed ID: 18607876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of targeted therapies in advanced gastric cancer: promising exploratory steps in a new era.
    Wagner AD; Moehler M
    Curr Opin Oncol; 2009 Jul; 21(4):381-5. PubMed ID: 19412098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Melanoma: a new therapeutic era].
    Berthod G; Homicsko K; Bouchaab H; Matter M; Cerottini JP; Guggisberg D; Speiser D; Leyvraz S; Michielin O
    Rev Med Suisse; 2011 May; 7(296):1126-30. PubMed ID: 21721201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.